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ABSTRACT:  The acute oral toxicity of the anticoagulant rodenticide diphacinone was found to be about 20 times greater to 
American kestrels (LD50=97 mg/kg) than to northern bobwhite (LD50=2,014 mg/kg).  Several precise and sensitive clotting assays 
(prothrombin time, Russell’s Viper venom time, thrombin clotting time) were adapted for use in these species, and this combination 
of assays is recommended to detect effects of diphacinone and other rodenticides on coagulation.  Oral administration of 
diphacinone over a range of doses (sublethal to the extrapolated LD15) prolonged prothrombin time and Russell’s Viper venom time 
within 24 to 48 hrs post-exposure.  Prolongation of in vitro clotting time reflects impaired coagulation complex activity and was 
detected before or at the onset of overt signs of toxicity and lethality.  These data will assist in the development of a pharmaco-
dynamic model to assess and predict rodenticide toxicity to non-target avian species. 
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INTRODUCTION 
In the past 15 years, several current use anticoagulant 
rodenticides have been identified as potential hazards to 
predatory and scavenging birds, and adverse effects have 
been reported in many countries (e.g., Newton et al. 1990, 
Eason and Spurr 1995, Howald et al. 1999, Stone et al. 
1999, 2003; Lambert et al. 2007, Walker et al. 2008, 
Albert et al. 2009).  For example, in the state of New 
York between 1971 and 1997 there were at least 51 
confirmed cases of death by hemorrhage with detection of 
rodenticides in tissues of wildlife (Stone et al. 1999).  A 
surveillance program (1998 to 2001) reported that nearly 
half of the 265 raptors examined had detectable quantities 
of anticoagulant rodenticides in liver tissue, and these 
compounds were considered the cause of death in about 
15% of these cases (Stone et al. 2003).  Many of the 
incidents involved birds of prey, particularly great horned 
owls (Bubo virginianus) and red-tailed hawks (Buteo 
jamaicensis), that consume exposed or poisoned rodents.  
The global magnitude of secondary poisoning by rodenti-
cides in birds is unknown, as most events are probably 
unnoticed or not reported.   
A risk assessment by the U.S. Environmental Protec-
tion Agency (US EPA) identified several rodenticides 
that pose a significant risk to birds and non-target 
mammals (Erickson and Urban 2004), and subsequently 
some restrictions were placed on the sale, distribution, 
and packaging of brodifacoum, difethialone, bromadi-
olone, and difenacoum (US EPA 2008).  This action may 
be offset by expanded use of other anticoagulant rodent-
cides, including diphacinone.  The hazard of diphacinone 
to non-target organisms is inadequately characterized.  
Accordingly, sublethal responses (blood clotting time) 
and lethality were determined in northern bobwhite 
(Colinus virginianus), a species traditionally used in wild-
life pesticide risk assessments, and also in the American 
kestrel (Falco sparverius), a well-studied toxicological 
model for raptorial species (Bardo and Bird 2009).  
Rather than using ad libitum dietary exposure in which 
food consumption can be highly variable, a controlled 
oral dosing regimen was employed to more accurately 
estimate dose-related sublethal and lethal effect thre-
sholds.  These and other data will ultimately assist in the 
development of a pharmacodynamic model of dipha-
cinone in birds, and also in selection of efficacious baiting 
strategies that may mitigate risk to non-target species. 
 
METHODS 
Animals  
Adult northern bobwhite were obtained from R & R 
Game Birds (Lamar, CO), housed individually in indoor 
pens (61 cm × 46 cm × 33 cm high) at the USDA 
National Wildlife Research Center, Fort Collins, CO 
(NWRC), maintained in a 12 hr light:12 hr dark photo-
period at 18-21ºC, and provided food (Purina Game Bird 
Maintenance Chow® Product 5440, 12.5% protein, 
Denver, CO) and water ad libitum.  Body weight of quail 
ranged from 149-224 g.  American kestrels were propa-
gated in the captive colony of the USGS Patuxent 
Wildlife Research Center, Laurel, MD (PWRC) (Porter 
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and Wiemeyer 1970), where they were maintained in 
outdoor flight pens (6.1 m × 2.4 m × 2.1 m high), and 
provided daily rations of either Classic Bird of Prey diet 
(Nebraska Brand, North Platte, NE) supplemented with 
Vionate® (Gimborn US, Atlanta, GA), dead mice (Mus 
musculus), or dead hatchling chickens (Gallus gallus), 
and water.  Body weight of kestrels ranged from 98-132 
g.  
 
Acute Toxicity of Diphacinone 
An acute oral toxicity test was conducted in which 
quail were gavaged with technical grade diphacinone 
(99% active ingredient) (Hacco, Inc. Randolph, WI) 
suspended in vegetable oil (Crisco®, Orville, OH).  Doses 
ranging from 917 to 3,666 mg/kg body weight (n = 9-10 
quail/dose; about equal sex distribution/dose) were 
selected through a stepwise process.  Due to the low 
solubility of diphacinone, birds in 4 of the treatment 
groups received multiple doses within a 24-hr period 
(total amount administered: 1,033 and 2,065 mg/kg – 2 
doses/day; 2,868 mg/kg – 3 doses/day; and 3,666 mg/kg – 
4 doses/day).  The heaviest bird in a dosage group 
received 1 ml of the suspension, and the remaining quail 
in that group received a fraction of the volume 
determined by their weight.  Vegetable oil (vehicle) was 
administered 1-3 times to 9 quail that served as controls.  
Birds were observed twice daily for signs of toxicity for 
14 days.   
Using the results of the bobwhite acute toxicity test, 
range finding trials with kestrels were undertaken.  
Serious problems were encountered due to regurgitation 
of diphacinone.  Through an iterative process, a dosing 
procedure was developed that minimized regurgitation.  
In September and October 2009, kestrels were moved 
from their flight pens to small outdoor cages (1.2 m × 0.8 
m × 0.6 m high containing a rope perch, food tray, and 
water bowl) where they were housed individually and fed 
Classic Bird of Prey diet for at least a 10-day acclimation 
period.  Following an overnight fast, small quantities of 
neat diphacinone (<200 mg/kg), freeze-dried bird of prey 
diet, and 5 µl FD&C Blue #1 food dye (to better detect 
regurgitation; McCormick & Co., Inc., Baltimore, MD) 
were loaded into a number 4 gelatin capsule (E. Lilly and 
Co., Indianapolis, IN) that was administered to the level 
of the proventriculus using a pilling device (modified pet 
piller, Jorgetsen Laboratories, Inc., Loveland, CO) and a 
plastic probe.  The capsule was chased with 0.2 ml of 
distilled water by gavage, and the dosed kestrel was 
returned to its pen and immediately presented with a 
highly desired food item (i.e., dead chicken hatchling).  
By repeating this procedure 4 times within a 24-hr period, 
total daily dosages ranging from 35.1 to 675 mg/kg body 
weight were achieved (n=19 kestrels, with sexes divided 
near evenly among dosages, plus 4 controls that received 
capsules containing only the freeze-dried diet and blue 
dye).  Pens were lined with kraft paper to monitor 
regurgitation, and kestrels were observed for overt signs 
of intoxication several times each day for a week. 
 
Effects of Diphacinone on Clotting Time 
Based upon the results of the acute toxicity test in 
quail, another study was conducted in which bobwhite 
were gavaged with either vegetable oil (control, n=6), 434 
mg diphacinone/kg body weight (n=16), or 783 mg 
diphacinone/kg (n=16).  Quail were euthanized and im-
mediately bled by cardiac puncture at 6, 12, 24, and 48 
hrs post-dose, and controls were sacrificed and bled at 48 
hrs post-dose.  Blood samples (~0.5 ml) were collected 
into syringes containing 50 µl of 0.5 M  EDTA, a suitable 
alternative to sodium citrate (Cerón et al. 2008).  The 
samples were centrifuged, plasma was harvested and 
frozen at -80ºC, and subsequently shipped to PWRC for 
analysis. 
Using the aforementioned protocol from the kestrel 
acute toxicity trial, another kestrel diphacinone study was 
conducted in which a total of 50 mg/kg body weight was 
administered as divided doses over a 24-hr period.  
Controls were treated similarly except capsules did not 
contain diphacinone.  At 48 hrs after administration of the 
final capsule, a 0.9-ml jugular venipuncture sample was 
drawn into a syringe containing 0.1 ml of 3.2% sodium 
citrate (n=3 diphacinone-treated and n=3 control kestrels), 
and blood samples were collected from the remaining 
birds (n=3 diphacinone-treated and n=2 controls) after 
168 hrs.  Blood samples were centrifuged and citrated 
plasma was frozen at -80ºC for clotting time assays. 
 
Figure 1.  Blood coagulation pathway in birds (adapted from 
Gentry 1993 and Thomson et al. 2002; F = Factor, PL = 
phospholipid). 
 
One-Stage Prothrombin Time Assay 
An excess of tissue factor and phospholipid 
(thromboplastin) interacts with plasma Factor VII to form 
an active complex, and through a cascade of reactions 
fibrinogen is eventually converted to fibrin which forms a 
clot (Figure 1).  Crude chick hatchling thromboplastin 
(CHT) was prepared by the method of Quick as modified 
by Griminger et al. 1970 and Doerr et al. 1975.  The CHT 
(50 mg) was suspended in 2,500 µl of 25 mM CaCl2, and 
incubated at 42ºC for 15 min with intermittent vortexing.  
Following centrifugation of the suspension (1,500 × g for 
20 min), the supernatant was diluted (1:1) with 25 mM 
CaCl2 (~220 µg protein/ml).  Clotting time was deter-
mined using a BBL fibrometer (Becton Dickson & Co., 
Baltimore, MD).  Plasma (100 µl) was incubated at 37ºC 
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for 2 min, and the reaction was initiated by the addition of 
200 µl of diluted CHT.  Intra-assay precision (mean 
coefficient of variation ± standard deviation) for duplicate 
determinations of quail and kestrel plasma was 4.6 ± 
4.5% (n=30) and 2.0 ± 2.2% (n=11), respectively.  Inter-
assay precision over the course of a year for human 
reference samples using Simplastin® (rabbit brain 
thromboplastin; Trinity Biotech, Berkeley Heights, NJ) 
was 2.9 ± 2.2% (n=13).  When a quail or a kestrel plasma 
pool was diluted with 8.3 mM Na/K phosphate buffer 
(pH 7.2), clotting time was relatively stable at dilutions 
containing as little as 50% plasma, but increased at 
greater dilution. 
 
Russell’s Viper Venom Time (RVVT) 
Russell’s Viper venom (RVV) directly activates 
Factor X (but not Factor VII ) in the common pathway of 
the clotting cascade (Figure 1).  Reconstituted RVV 
Factor X activator (American Diagnostica, Stamford, CT) 
was diluted 1:10 with imidazole buffered saline (IBS; 
0.0125 M imidazole 0.109 M NaCl, pH7.4) and main-
tained at room temperature.  Plasma (100 µl) was incu-
bated at 37ºC in a sample cup for 2 min, and 100 µl of 
diluted RVV was added and incubated for 15 sec.  The 
reaction was initiated with 100 µl 25 mM CaCl2, and 
clotting time was determined (Triplett and Harms 1981a).  
Intra-assay precision for duplicate determinations of quail 
plasma was 6.5 ± 13.5% (n=19) and kestrel plasma was 
3.4 ± 4.1% (n=9).  Clotting time remained relatively 
stable when quail or kestrel plasma was diluted by as 
much as 60% with phosphate buffer, but RVVT increased 
dramatically at greater dilutions. 
 
Thrombin Clotting Time (TCT) 
This assay measures the time for conversion of 
fibrinogen to fibrin (Figure 1) using a standard thrombin 
solution (Triplett and Harms 1981b).  The assay is an 
indicator of the amount of fibrinogen in the plasma 
sample, and insensitive to deficiency of vitamin K-
dependent clotting factors.  We used the AMAX 
Fibrinogen kit (Trinity Biotech) which includes bovine 
thrombin reagent and human fibrinogen reference ma-
terial.  A fibrinogen standard curve was prepared (65 to 
520 mg/dL), and quail or kestrel plasma samples were 
diluted 1:10 with IBS.  Diluted plasma (200 µl) was 
incubated at 37ºC in a sample cup for 2 min, and the 
reaction initiated by the addition of 100 µl of thrombin 
reagent.  Clotting time of the test sample was transformed 
to fibrinogen concentration (mg/dL) from the standard 
curve.  Intra-assay precision for duplicate determinations 
of quail plasma was 5.7 ± 6.8% (n=32) and kestrel 
plasma was 1.8 ± 2.2% (n=9). 
 
Statistical Methods 
For the acute toxicity trial, the median lethal dose 
(LD50) of diphacinone in bobwhite and kestrels was 
estimated using probit analysis (SAS Institute, Carey, 
NC).  For sublethal dosing studies, prothrombin time, 
RVVT, and TCT were tested for homogeneity of variance 
(Fmax test) and normality (Shapiro-Wilk test, normal 
probability plot and descriptive statistics).  The measure-
ment endpoints were then compared by one-way analysis 
of variance (ANOVA) in the quail study and by a 2 × 2 
factorial ANOVA (dosage × time) in the kestrel study.  
Tukey’s HSD test was used as a mean separation proce-
dure. 
 
RESULTS 
Acute Toxicity Studies 
Survival of northern bobwhite was significantly 
related (P < 0.0001) to dose of diphacinone (survivors: 9 
of 10 at 917 mg/kg; 8 of 9 at 965 mg/kg; 10 of 10 at 
1,033 mg/kg; 7 of 10 at 2,065 mg/kg; 1 of 10 at 2,868 
mg/kg; 0 of 10 at 3,666 mg/kg).  Bobwhite receiving the 
greatest doses (2,868 and 3,666 mg/kg) succumbed 
within 1-3 days of exposure.  Some dosed quail exhibited 
subcutaneous bruises on the breast and back regions 
which could reflect coagulopathy; however, there was no 
evidence of frank internal or external bleeding.  All 
vehicle-dosed controls survived the 14-day trial.  The 
LD50 estimate was 2,014 mg/kg (95% confidence interval 
1,620-2,475 mg/kg), and the slope of the dose-response 
curve was steep (probit/log10 ± SE = 9.92 ± 2.27).   
Survival of American kestrels was also significantly 
related (P < 0.023) to dose of diphacinone (survivors: 2 of 
2 at both 35.1 and 52.7 mg/kg, 2 of 3 at 79.0 mg/kg, 0 of 
3 at 118.6 mg/kg, 0 of 2 at 177.8 mg/kg, 0 of 1 at 200 
mg/kg, 1 of 1 at 266.7 mg/kg, 0 of 2 at 300 mg/kg, 0 of 1 
at both 450 and 675 mg/kg).  Sample size for two 
intermediate doses was only 1, as a bird scheduled to 
receive 266.7 mg/kg died before the final capsule 
containing its divided dose could be administered.  Birds 
scheduled to receive 600 and 900 mg/kg died before the 
final divided dose could be given, so the actual 
administered doses were 450 and 675 mg/kg.  Kestrels 
that succumbed appeared to exhibit a progression of toxic 
signs (loss of balance on perch, standing on floor of pen 
rather than perch, non-reactive when approached, 
subdued behavior, appearance of tan urate deposits) and 
died between 10 to 48 hrs after receiving the initial 
capsule of the divided dose.  Two kestrels (266.7 and 79.0 
mg/kg doses) exhibited toxic signs, but appeared to 
recover by the third day of the trial.  All controls survived 
the 7-day trial.  The LD50 of diphacinone for kestrels was 
estimated to be 97 mg/kg (95% confidence interval 38-
219 mg/kg), and the slope of the dose-response curve was 
6.69 ± 2.94 probit/log10.   
 
Sublethal Exposure and Effects on Clotting Time  
In the quail study, the 434 mg/kg dose was slightly 
greater than the lower 95% confidence limit of the LD01, 
while the 783 mg/kg dose fell between the estimated LD01 
and LD02.  Both of these doses prolonged clotting time 
when compared to controls, but the temporal response 
was highly variable (e.g., see scatter of prothrombin times 
in Figure 2).  However, fibrinogen concentration in 5 
samples as determined in the TCT assay was undetecta-
ble, and the volume of another sample was too small to 
determine fibrinogen concentration.  The absence of 
fibrinogen in these samples suggest that they may have 
been collected improperly (viz., cardiac puncture of 
euthanized birds, partially clotted blood).  Fibrinogen is 
generally in great excess, and its conversion to fibrin in 
the TCT assay is not influenced by vitamin K antagonists. 
148
Figure 2.  Prothrombin time (mean ± standard deviation; 
     = data point) of all quail gavaged with vehicle (control) 
or at 6, 12, 24, and 48 hrs following administration of 
diphacinone.  
Figure 3.  Prothrombin time of quail gavaged with vehicle 
(control) or diphacinone (6, 12, 24, and 48 hrs post-dose) 
with plasma fibrinogen concentration >60 mg /dL. 
 * = significantly different (P < 0.05) than control. 
Figure 4.  Russell’s Viper venom time of quail gavaged with 
vehicle or diphacinone (6, 12, 24, and 48 hrs post-dose) 
with plasma fibrinogen concentration >60 mg /dL. 
  * = significantly different (P < 0.05) than control. 
When these 6 samples were excluded, the remaining 
samples contained more than 60 mg fibrinogen/dL  
(range: 63 to 254 mg/dL, n=32).  For these remaining 
samples, prothrombin time and RVVT (Figures 3 and 4) 
were prolonged about three- to four-fold (P < 0.05) at 48 
hrs after administration of 434 mg/kg, and similarly 
prolonged by 783 mg/kg at both 24 hrs and 48 hrs (P < 
0.05), when compared to the control group.   
In the kestrel study, the 50 mg/kg dose fell between 
the estimated LD10 and LD15, and all birds survived the 
trial.  However, one diphacinone-dosed kestrel was 
subdued on days 2 and 3, and before it was bled a 
subcutaneous hematoma was observed on its neck.  A 
significant dose × time interaction was detected by 
ANOVA for both prothrombin time (P < 0.023) and 
RVVT (P < 0.027).  Diphacinone prolonged prothrombin 
time (P < 0.036) and RVVT (P < 0.032) in blood samples 
collected 48 hrs after administration of the final capsule 
of the divided dose, but after 7 days clotting times 
returned to control values (Figures 5 and 6).  Fibrinogen 
concentration was detectable in all samples (range: 45 to 
147 mg/dL) and did not differ (P > 0.15) among the 4 
groups.  
Figure 5.  Prothrombin time of kestrels administered 4 
capsules containing diphacinone (50 mg/kg over 24 hrs 
in divided doses) or capsules without rodenticide 
(control) at 48 and 168 hrs post-dose.  
 * = significantly different (P < 0.05) than concurrent control. 
Figure 6.  Russell’s Viper venom time of kestrels 
administered 4 capsules containing diphacinone (50 
mg/kg over 24 hrs in divided doses) or capsules without 
rodenticide (control) at 48 and 168 hrs post-dose. 
 * = significantly different (P < 0.05) than concurrent control. 
* 
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DISCUSSION  
Diphacinone may be categorized as only slightly toxic 
(LD50 2,014 mg/kg) to northern bobwhite using tradi-
tional categories that classify harm (Loomis 1978).  A 
reliable diphacinone median lethal dose for bobwhite 
could not be estimated in a previous study (Campbell et 
al. 1991) as dosages were separated by a factor of 5, but 
inspection of the data suggest that the theoretical value 
fell between 400 and 2,000 mg/kg (US EPA 1998).  Our 
estimated LD50 in quail is of the same order of magnitude 
as reported for mallards (Anas platyhrynchos; 3,158 
mg/kg) (Erikson and Urban 2004).  Based upon data from 
avian species commonly used in pesticide registration 
tests (viz., northern bobwhite, mallards), diphacinone 
appears to be less toxic to captive birds than to laboratory 
rats and domesticated mammals (range of estimated 
LD50:  0.8 to 15 mg/kg), and to wild mammals (0.2 to 340 
mg/kg), and its risk to wild birds would seemingly be 
minimal (reviewed in Erikson and Urban 2004, Eisemann 
and Swift 2006).  However, results of the diphacinone 
acute toxicity test in American kestrels (LD50 97 mg/kg) 
indicate that they are over 20 times more sensitive than 
bobwhite, and over 30 times more sensitive than 
mallards.  Furthermore, a small dosing trial in which 
diphacinone-poisoned mice (Peromyscus maniculatus) 
were fed to great-horned owls (Buto virginianus) and a 
saw-whet owl (Aegolius acadicus) also suggests that they 
are more sensitive than bobwhite (Mendenhall and Pank 
1980).  Notably, diphacinone has been linked to second-
ary poisoning in raptors (Stone et al. 1999, 2003), and in 
general, raptors are more sensitive to pesticides than other 
groups of birds (Wiemeyer and Sparling 1991, Vyas et al. 
1998, Mineau et al. 1999).  These findings indicate that 
extrapolation of diphacinone toxicity data from quail and 
mallards to other avian Orders (e.g., Falconiformes, 
Stringiformes) may be dubious, and protection of raptors 
may require substantial safety factors.   
Some kestrels that survived dosing trials exhibited 
behavioral changes (e.g., 1 dosed at 266.7 mg/kg, and 1 
of 3 dosed at 79.0 mg/kg) and prolonged clotting time (2 
of 3 dosed at 50 mg/kg).  Similarly, golden eagles (Aquila 
chrysaetos) fed muscle from sheep dosed with dipha-
cinone (30 mg/kg) were weakened and debilitated and 
had prolonged prothrombin time (Savarie et al. 1979).  In 
both of these studies animals recovered, but such 
behavioral and physiological deficits could affect survival 
of free-ranging birds.   
Several coagulation assays were adapted that yielded 
short and precise clotting times with EDTA-treated plas-
ma from quail and citrated plasma from kestrels.  Using a 
thromboplastin extract from chick hatchlings, prothrom-
bin time of untreated quail (mean ± standard deviation:  
15.2 ± 1.5 sec, Figure 3) and kestrels (10.6 ± 0.8, Figure 
5) was in the range of values reported for many species of 
domesticated and wild birds (Martin et al. 1994, reviewed 
in Powers 2000, Thomson et al. 2002, Morrisey et al. 
2003, Rattner et al. 2009, Webster 2009).  Using RVV 
that activates Factor X in the common pathway, clotting 
time of plasma from untreated quail (39.5 ± 8.9 sec, 
Figure 4) and kestrels (22.6 ± 2.8, Figure 6) was slightly 
greater than reported in other avian species (~9 to 21 sec; 
Tahira et al. 1977, Timms 1977), although precision for 
duplicate RVVT determinations and standard deviation of 
control samples with >45 mg fibrinogen/dL, seems ac-
ceptable.    
Anticoagulant rodenticides inhibit vitamin K-
dependent post-translational processing of clotting 
Factors II (prothrombin), VII, IX, and X (reviewed in 
Powers 2000), but do not affect the synthesis of 
fibrinogen.  Fibrinogen deficiency resulting from im-
proper sample collection and from pathophysiologic 
conditions (e.g., hepatic synthetic failure, disseminated 
intravascular coagulation) can prolong in vitro clotting 
time.  Avian studies examining anticoagulant rodenticide 
toxicity have failed to determine if sample fibrinogen 
content supports in vitro clot formation.  A concentration 
threshold that supports clotting has yet to be established 
for birds, and in the interim, we used 60 mg/dL in quail 
and 45 mg/dL in kestrels.  A conservative diagnostic 
approach for anticoagulant rodenticide studies that 
evaluate vitamin K-dependent coagulopathies would 
entail a combination of assays, namely prothrombin time 
and/or RVVT, plus determination of fibrinogen (TCT) to 
rule out any nonspecific influence on clotting time. 
In the present study, several quail plasma samples did 
not contain detectable quantities of fibrinogen, failed to 
clot in both the in vitro one-stage prothrombin time and 
RVVT assays, and thus were excluded from our 
evaluation of diphacinone on hemostasis in quail.  
Clotting time of samples with detectable fibrinogen was 
not affected at 6 and 12 hrs after administration of 
diphacinone, but was prolonged at 24 and 48 hrs post-
dose.  In kestrels, effects on clotting time were apparent at 
48 hrs after administration of the final divided dose of 
diphacinone.  This time course roughly corresponds with, 
and may precede, the onset of overt toxicity and lethality 
at greater dosage levels used in the acute toxicity studies.  
The lag time between dosing and development of 
coagulopathy reflects the half-life clearance of functional 
coagulation factors and the increasing circulation of des-
carboxy, dysfunctional factors.  Prothrombin time is used 
as an early indicator of anticoagulant rodenticide 
ingestion in domestic mammals (Mount and Feldman 
1983), and is routinely measured to monitor coumadin 
anticoagulant therapy in humans (Spinler et al. 2005).  
Prolonged prothrombin times have been reported within 
days of 1) dietary exposure to the anticoagulant 
rodenticides diphacinone (golden eagles, Savarie et al. 
1979; American crow, Corvus brachyrhynchos, Massey 
et al. 1997), warfarin (chickens, Veltmann et al. 1981) 
and brodificoum (Japanese quail, Coturnix coturnix, 
Webster 2009), and 2) repeated gavage with pindone 
(wedge-tailed eagles, Aquila audax, bronzewing pigeons, 
Phaps chalcoptera, Port Lincoln parrots, Barnardius 
zonarius, black ducks, Anas supercillosa, Australian 
magpies, Gymnorhina tibicen, Martin et al. 1994).  
In conclusion, diphacinone was found to be consider-
ably more toxic to American kestrels than to northern 
bobwhite.  A group of clotting assays were developed and 
applied for use in quail and kestrels that are sensitive, 
precise, linked to the pathogenesis of toxicity (and 
ultimately mortality), and together have applicability as 
biomarkers in both laboratory studies and field 
monitoring.  These findings and assay methods will assist 
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in rodenticide hazard and risk assessments of secondary 
poisoning in non-target avian species.  
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